Volition to reveal new cancer detection method insights at upcoming webinar

Henderson, nev. , oct. 2, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, is taking part in a webinar hosted by edison group, to expound new cancer data to be presented on october 21 st at esmo 2023, the annual congress of the european society for medical oncology.

VNRX Ratings Summary

VNRX Quant Ranking